Why the study?
Does intravenous procainamide alter the inducibility of ventricular tachyarrhythmias in dogs with experimental myocardial infarction?
Does intravenous procainamide alter the inducibility of ventricular tachyarrhythmias in dogs with experimental myocardial infarction?
In a canine model of myocardial infarction, procainamide exhibited a proarrhythmic effect by converting inducible ventricular fibrillation to sustained ventricular tachycardia, suggesting caution for its use in post-MI patients.
Answers are grounded in this paper and cite their sources.
Procainamide may promote sustained VT over VF in postinfarct models; leaves open relevance to human arrhythmia management.
UNLABELLED: The influence of procainamide on inducible ventricular tachyarrhythmias was evaluated in 35 dogs with experimental myocardial infarction, and 9 normal dogs. Programmed stimulation was performed from the right ventricular apex via a percutaneously positioned electrode catheter, using up to five extrastimuli before and after intravenous administration of procainamide (15 mg/kg). Procainamide levels in postinfarct dogs were 8.5 +/- 0.7 micrograms/mL (range 5.3-13.6 micrograms/mL). Procainamide exerted its greatest effect in postinfarct dogs with reproducible baseline ventricular fibrillation. Six of nine dogs (P less than 0.05) with ventricular fibrillation had sustained monomorphic ventricular tachycardia (cycle length: 147 +/- 4 msec) induced after procainamide administration. This ventricular tachycardia required significantly more extrastimuli than baseline ventricular fibrillation (3 +/- 0.3 extrastimuli before vs 4 +/- 0.3 extrastimuli after procainamide). Procainamide never converted ventricular fibrillation to ventricular tachycardia in normal dogs. Procainamide had minimal effect on inducible ventricular tachycardia after myocardial infarction. Ventricular tachycardia induction was abolished in only 2 of 17 dogs despite significant prolongation of electrophysiological parameters. Ventricular tachycardia cycle length, and the number of extrastimuli required were unchanged by procainamide in this subgroup. CONCLUSION: Ventricular tachycardia is insensitive to the antiarrhythmic properties of procainamide in this model. In contrast, procainamide is able to convert postinfarction ventricular fibrillation to ventricular tachycardia, presumably by promoting sustained, organized reentry. This previously undescribed action is an unusual form of proarrhythmic effect, and suggests that this drug should be used cautiously in patients after myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Hunt et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: